Targeting FGFR Mutations in Metastatic Urothelial Cancer

Drs Arlene O. Siefker-Radtke and Scott T. Tagawa comment on opportunities for treating metastatic urothelial cancer with FGFR targeted therapies based on current trends in molecular testing and emerging therapies.

EP. 1: Testing for FGFR Mutations in Metastatic Urothelial Cancer

November 10th 2021

A discussion on current prognostic and predictive testing assays used to detect FGFR mutations in patients with metastatic urothelial cancer (mUC).

EP. 2: Tissue and Liquid Biopsies in Metastatic Urothelial Cancer

November 10th 2021

A discussion on current prognostic and predictive testing assays used to detect FGFR mutations in patients with metastatic urothelial cancer (mUC).

EP. 3: Molecular Testing in Metastatic Urothelial Cancer During COVID-19

November 17th 2021

The impact of the COVID-19 pandemic on rates of molecular testing used by community oncologists who care for patients with urothelial cancer.

EP. 4: Barriers to Molecular Testing in Metastatic Urothelial Cancer

November 17th 2021

A discussion on molecular testing in the community and recommendations that can address barriers.

EP. 5: Multidisciplinary Care in Metastatic Urothelial Cancer

November 24th 2021

An overview of the types of health care professionals who may help manage patients with metastatic urothelial cancer throughout their disease course.

EP. 6: Genomic Profiling Assays in Metastatic Urothelial Cancer

November 24th 2021

The significance of using broad genomic profiling tests to help detect promising biomarkers in metastatic urothelial cancer.

EP. 7: Treatment Planning for a Patient With Metastatic Urothelial Cancer

December 1st 2021

Drs Arlene O. Siefker-Radtke and Scott T. Tagawa explain how they would establish goals of therapy and a treatment algorithm for a patient who presents with metastatic urothelial cancer.

EP. 8: Frontline Therapy for Metastatic Urothelial Cancer

December 1st 2021

Factors that impact the selection of immunotherapy vs chemotherapy for frontline metastatic urothelial cancer.

EP. 9: Repeat Molecular Testing in Metastatic Urothelial Cancer

December 6th 2021

Current recommendations for repeat testing in patients with relapsed metastatic urothelial cancer.

EP. 10: FGFR-Targeted Therapy for Metastatic Urothelial Cancer

December 6th 2021

Strategies that can be used to counsel patients on molecular testing for FGFR mutations and what to expect from treatment with erdafitinib.